4//SEC Filing
Chawla Lakhmir S 4
Accession 0000920465-20-000135
CIK 0000920465other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:18 PM ET
Size
7.0 KB
Accession
0000920465-20-000135
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-08-14$3.34/sh+589$1,967→ 12,611 total - Award
Employee Stock Option (Right to Buy)
2020-08-14+589→ 589 totalExercise: $3.93Exp: 2030-08-14→ Common Stock (589 underlying)
Footnotes (2)
- [F1]These shares were acquired on 08/14/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001646626
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:18 PM ET
- Size
- 7.0 KB